Risk to Healthcare Workers From Use of CPAP, High Flow Nasal O2 for COVID-19?
Does use of CPAP or high-flow nasal oxygen by inpatients with COVID-19 expose nearby healthcare workers to a greater risk of viral contamination?
Does use of CPAP or high-flow nasal oxygen by inpatients with COVID-19 expose nearby healthcare workers to a greater risk of viral contamination?
Clinical trial results indicate that ciclesonide inhalation may be an effective early antiviral therapy for mild to moderate COVID-19.
Can peripheral oxygen saturation levels be used instead of arterial blood gas analysis to calculate SOFA scores in patients with suspected sepsis?
Researchers examining COVID-19 data from a 13-month period found variations in US usage of dexamethasone, remdesivir, and hydroxychloroquine.
An NIH review explored whether Bruton tyrosine kinase inhibitors decreased oxygen requirements and hospitalizations for patients with SARS-CoV-2.
Further metabolite-based analysis may help identify the mechanisms underlying pulmonary dysfunction in COVID-19 survivors and provide potential therapeutic targets in the future.
In patients requiring mechanical ventilation for ARDS related to COVID-19, combining the lung ultrasound aeration score and the recruitment-to-inflation ratio can provide additional information on lung recruitment.
Light sedation with dexmedetomidine does not lead to more days alive without acute brain dysfunction compared with propofol in mechanically ventilated adults with sepsis.
There appears to be a low risk of invasive fungal secondary infection, especially aspergillosis, in patients with SARS-CoV-2-related pneumonia and no underlying immunosuppression.
Vitamin D deficiency is associated with a higher risk of incident nontuberculous mycobacteria respiratory isolation in adults with cystic fibrosis.